Novartis is attending the 42nd Annual J.P. Morgan Healthcare Conference from January 8-11, 2024 in San Francisco, California.
Latest news and interviews for media and investors
Jan 08, 2024
Webcast recording
Highlights include:
- Focused strategy
- Robust pipeline
- Attractive growth prospects
- ESG leader
Highlights of the presentation
Transformation into innovative medicine company
Explore how our transformation progress has driven performance
Prioritized and enhanced pipeline
Discover how we deliver high-value medicines across core therapeutic areas through strategic approaches
Continuing to build trust with society
With focus on material ESG factors that drive value whilst mitigating risks
In the news
Novartis CEO Vasant Narasimhan: The right story for the company was to focus on R&D
CNBC | Jan 9, 2024
Strategy
Learn about the Novartis strategy and explore our core therapeutic areas and technology platforms.
Investor Relations
We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.